Miv Therapeutics, Inc. (IVT) Reports Q3 EPS of $0.06

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of $0.06. Revenue for the quarter came in at $50.89 million.

GUIDANCE:

Miv Therapeutics, Inc. sees FY2021 EPS of ($0.20)-($0.16).

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLY) Tops Q1 EPS by 4c ; Offers Guidance
• Smith & Wesson Brands (SWBI) Tops Q1 EPS by 13c
• Mama's Creations, Inc. (MAMA) Tops Q3 EPS by 1c